跳至主要内容
临床试验/NCT03114631
NCT03114631已完成1 期

Single-center Trial Evaluating the Safety and Efficacy of MUC-1/WT-1 Peptide or Tumor Lysate-pulsed Dendritic Cell Immunotherapy for the Patients With Pancreatic Cancer

The Republican Research and Practical Center for Epidemiology and Microbiology2 个研究点 分布在 1 个国家目标入组 30 人开始时间: 2017年1月9日最近更新:
适应症

试验速览

阶段
1 期
状态
已完成
发起方
入组人数
30
试验地点
2
主要终点
Number of Participants Who Survived at 1 Year

研究概览

简要总结

The trial evaluates the safety and efficacy of MUC-1/WT-1 peptide and/or tumor lysate-pulsed dendritic cell Immunotherapy for the patients with pancreatic cancer

详细描述

The trial evaluates the safety and efficacy of dendritic cell Immunotherapy for the patients with pancreatic cancer. Dendritic cells are obtained from blood monocytes using standard protocol.

Two options for dendritic cell priming are used: MUC-1/WT-1 peptides for the patients with unresectable tumor and/or tumor lysates for the patients undergoing tumor resection.

The dendritic cells are them matured and injected subcutaneous (all patients) and intratumorally (when possible).

研究设计

研究类型
Interventional
分配方式
Non Randomized
干预模型
Parallel
主要目的
Treatment
盲法
None

入排标准

年龄范围
18 Years 至 85 Years(Adult, Older Adult)
性别
All
接受健康志愿者

入选标准

  • histologically or cytologically confirmed pancreatic cancer (adenocarcinoma);
  • HLA-A2 expression by tumor cells;
  • WT-1/MUC-1 expression by tumor cells.

排除标准

  • refuse of patient to participate in the trial;
  • pregnancy/lactation;
  • intercurrent severe chronic diseases;
  • HIV, Hepatites B/C;
  • active tuberculosis;
  • alcohol use disorder/drug addiction.

结局指标

主要结局

Number of Participants Who Survived at 1 Year

时间窗: 1 year

1 year overall survival

Number of Participants with PR or CR at 1 year

时间窗: 1 year

1 year PR/CR

次要结局

  • Number of Participants Who Survived at 3 Years or more(3 years)
  • Immune response(1 year)
  • Antigen-specific immune response(1 year)
  • Circulating tumor cells count(1 year)
  • Number of Participants Who Survived at 2 Years(2 years)

研究者

发起方
The Republican Research and Practical Center for Epidemiology and Microbiology
申办方类型
Other
责任方
Principal Investigator
主要研究者

Andrei Y. Hancharou

Head of the Laboratory for Immunology and Cellular Biotechnology

The Republican Research and Practical Center for Epidemiology and Microbiology

研究点 (2)

Loading locations...

相似试验